View Future GrowthRedcare Pharmacy 過去の業績過去 基準チェック /06Redcare Pharmacyは14.4%の年平均成長率で業績を伸ばしているが、Consumer Retailing業界はgrowingで12.9%毎年増加している。売上は成長しており、年平均25.3%の割合である。主要情報14.38%収益成長率22.40%EPS成長率Consumer Retailing 業界の成長10.91%収益成長率25.28%株主資本利益率-8.29%ネット・マージン-1.22%次回の業績アップデート29 Jul 2026最近の業績更新お知らせ • Feb 07Redcare Pharmacy NV to Report Q2, 2026 Results on Jul 29, 2026Redcare Pharmacy NV announced that they will report Q2, 2026 results on Jul 29, 2026お知らせ • Jan 08Redcare Pharmacy NV to Report Fiscal Year 2025 Final Results on Mar 04, 2026Redcare Pharmacy NV announced that they will report fiscal year 2025 final results at 9:00 AM, Central European Standard Time on Mar 04, 2026お知らせ • Oct 07Redcare Pharmacy NV to Report Q3, 2025 Results on Oct 29, 2025Redcare Pharmacy NV announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Mar 19Redcare Pharmacy NV to Report Q2, 2025 Results on Jul 29, 2025Redcare Pharmacy NV announced that they will report Q2, 2025 results on Jul 29, 2025お知らせ • Mar 11Redcare Pharmacy NV to Report Q1, 2025 Results on May 06, 2025Redcare Pharmacy NV announced that they will report Q1, 2025 results on May 06, 2025お知らせ • Jan 09Redcare Pharmacy NV to Report Fiscal Year 2024 Final Results on Mar 11, 2025Redcare Pharmacy NV announced that they will report fiscal year 2024 final results on Mar 11, 2025すべての更新を表示Recent updatesお知らせ • Apr 17Redcare Pharmacy N.V. Announces Board Appointment, Effective April 15, 2026Redcare Pharmacy N.V. announced that at its Annual General Meeting held on April 15, 2026, the shareholders voted with an absolute majority for all agenda items, including the appointment of Anja Hendel, Max Müller and Peter Schmid von Linstow as new members of the Supervisory Board. The Supervisory Board now consists of Michael Köhler (Chairman), Peter Schmid von Linstow (Vice-Chairman), Stephan Weber, Anja Hendel and Max Müller.お知らせ • Feb 07Redcare Pharmacy NV to Report Q2, 2026 Results on Jul 29, 2026Redcare Pharmacy NV announced that they will report Q2, 2026 results on Jul 29, 2026お知らせ • Jan 28Redcare Pharmacy N.V. Supports Seamless Continuation Of Digital E-Prescription Journey With PoPP Draft SpecificationsRedcare Pharmacy N.V. reported that the national agency responsible for the digitalization of the healthcare system in Germany (gematik) has published the draft specifications of the PoPP (Proof of Patient Presence) module for remote care use case, including the digital redemption of e-prescriptions. PoPP is intended to replace the current VSDM++ patient card verification process on which Redcare’s CardLink solution is based. In its current draft form, the PoPP specifications confirm the continuation of a smooth, low-threshold digital process for e-prescription redemption using Redcare’s Shop Apotheke app in Germany. The ability to verify the eGK and a patient’s insured status without PIN on the app can continue now even more effectively, since an SMS for mobile number verification will no longer be required. Combined with the added optionality of using a digital ID in the future, this ensures stability, more flexibility and supports the continued adoption of digital solutions. The migration to PoPP is part of a broader modernization of Germany’s telematics infrastructure. The new technology raises security standards for data protection while enabling more flexible, software-based authentication options. Beyond enhanced security, this approach is expected to improve accessibility to healthcare services, particularly in remote and digital care settings. Following the publication of the final PoPP specifications for the remote care use case – anticipated in the First Quarter 2026 – Redcare Pharmacy will finalize the technical implementation within its Shop Apotheke app and secure the required regulatory approvals. The official rollout of PoPP Stufe 2 – Online Check-in by gematik is currently planned for the end of 2026. Redcare Pharmacy’s CardLink license extension remains valid until January 31, 2027, providing ample runway for a smooth and well-managed transition.お知らせ • Jan 08Redcare Pharmacy NV to Report Fiscal Year 2025 Final Results on Mar 04, 2026Redcare Pharmacy NV announced that they will report fiscal year 2025 final results at 9:00 AM, Central European Standard Time on Mar 04, 2026お知らせ • Nov 12+ 1 more updateRedcare Pharmacy NV Designates Hendrik Krampe as Chief Financial Officer, Effective 1 December 2025Redcare Pharmacy announced that the Supervisory Board has designated Hendrik Krampe as Chief Financial Officer, effective 1 December 2025. The appointment of Hendrik Krampe is on the agenda of the Annual General Meeting to be held in April 2026 for consultation. The appointment of Hendrik Krampe is on the agenda of the Annual General Meeting to be held in April 2026 for consultation. Hendrik Krampe has twenty years of experience in the financial management of fast growing e-commerce businesses. Since 2014, he worked at Amazon where he held the role of Finance Director of the European marketplace business for the last eight years. From 2004 to 2014, Hendrik was at eBay in Germany as well as in the US in various roles including Finance Director of eBay’s Retail Media business. His broad expertise in efficiently scaling digital businesses, particularly marketplaces and Retail Media, complements Redcare Pharmacy´s strategy and will strengthen its core Rx and OTC business. The planned appointment of Hendrik comes at a time of continued growth momentum following strong third quarter results. It will support the company’s aim to increasingly capture economies of scale and improve profitability.お知らせ • Oct 07Redcare Pharmacy NV to Report Q3, 2025 Results on Oct 29, 2025Redcare Pharmacy NV announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Sep 28Redcare Pharmacy NV Announces Stepping Down of Jasper Eenhorst from the Management BoardRedcare Pharmacy NV announced that Jasper Eenhorst will stepping down from the Managing Board, but will remain with the company until the end of this year to support a smooth transition to his successor.お知らせ • Mar 19Redcare Pharmacy NV to Report Q2, 2025 Results on Jul 29, 2025Redcare Pharmacy NV announced that they will report Q2, 2025 results on Jul 29, 2025お知らせ • Mar 13Redcare Pharmacy NV Provides Earnings Guidance for 2025Redcare Pharmacy NV provided earnings guidance for 2025. The company expects Total sales growth in excess of 25%.お知らせ • Mar 11Redcare Pharmacy NV to Report Q1, 2025 Results on May 06, 2025Redcare Pharmacy NV announced that they will report Q1, 2025 results on May 06, 2025お知らせ • Jan 09Redcare Pharmacy NV to Report Fiscal Year 2024 Final Results on Mar 11, 2025Redcare Pharmacy NV announced that they will report fiscal year 2024 final results on Mar 11, 2025お知らせ • Oct 04Redcare Pharmacy NV Revises Sales Guidance for the Full Year 2024Redcare Pharmacy NV revised sales guidance for the full year 2024. The company expected for the full year 2024 that sales will end up slightly higher than predicted at the start of the year, and new guidance is total sales between EUR 2.35 billion and EUR 2.5 billion.お知らせ • Jul 30Redcare Pharmacy NV (XTRA:RDC) acquired MediService AG.Redcare Pharmacy NV (XTRA:RDC) acquired MediService AG on mid-May last year. Redcare Pharmacy NV (XTRA:RDC) completed the acquisition of MediService AG on mid-May last year.お知らせ • Mar 07Redcare Pharmacy NV Announces Management DeparturesThe Supervisory Board of Redcare Pharmacy NV agreed to the early departure request of the Managing Board members Stephan Weber (CCO) and Marc Fischer (CIO) at the Annual General Meeting on 17 April 2024. This decision comes at an ideal time to transition leadership responsibilities approximately one year before the end of their regular terms of office. This succession plan had been carefully developed and is the result of an extensive evaluation and selection process. Both Stephan Weber and Marc Fischer have agreed with the Supervisory Board to serve Redcare Pharmacy in an advisory capacity until October 2026, provided the relevant agenda item is approved by the Annual General Meeting.お知らせ • Mar 06+ 2 more updatesRedcare Pharmacy NV to Report Q3, 2024 Results on Nov 05, 2024Redcare Pharmacy NV announced that they will report Q3, 2024 results on Nov 05, 2024お知らせ • Mar 05Redcare Pharmacy NV, Annual General Meeting, Apr 17, 2024Redcare Pharmacy NV, Annual General Meeting, Apr 17, 2024, at 10:00 Central European Standard Time. Agenda: To consider directorate changes.お知らせ • Dec 20+ 3 more updatesShop Apotheke Europe N.V. to Report Fiscal Year 2022 Results on Mar 07, 2023Shop Apotheke Europe N.V. announced that they will report fiscal year 2022 results at 9:00 AM, Central European Standard Time on Mar 07, 2023収支内訳Redcare Pharmacy の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:SHPP.F 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Mar 263,073-37689031 Dec 252,941-38684030 Sep 252,821-35679030 Jun 252,676-35659031 Mar 252,528-48625031 Dec 242,371-45585030 Sep 242,227-25532030 Jun 242,128-9501031 Mar 241,987-10473031 Dec 231,799-12444030 Sep 231,595-16419030 Jun 231,404-45392031 Mar 231,272-65393031 Dec 221,204-78379030 Sep 221,165-110368030 Jun 221,118-105359031 Mar 221,081-91320031 Dec 211,060-74299030 Sep 211,037-39277030 Jun 211,038-29256031 Mar 211,020-18238031 Dec 20968-17214030 Sep 20895-15194030 Jun 20827-20182031 Mar 20758-27169031 Dec 19701-36166030 Sep 19660-41162030 Jun 19621-40151031 Mar 19584-40142031 Dec 18540-34127030 Sep 18481-31116030 Jun 18415-28104031 Mar 18351-2492031 Dec 17284-2180030 Sep 17244-2270030 Jun 17222-2063031 Mar 17200-2057031 Dec 16177-1850030 Sep 16159-1345030 Jun 16147-1343031 Mar 16136-1240031 Dec 15126-11360質の高い収益: SHPP.Fは現在利益が出ていません。利益率の向上: SHPP.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: SHPP.Fは利益を出していないが、過去 5 年間で年間14.4%の割合で損失を削減してきた。成長の加速: SHPP.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: SHPP.Fは利益が出ていないため、過去 1 年間の収益成長をConsumer Retailing業界 ( 12.2% ) と比較することは困難です。株主資本利益率高いROE: SHPP.Fは現在利益が出ていないため、自己資本利益率 ( -8.29% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YConsumer-retailing 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 22:59終値2026/05/19 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Redcare Pharmacy NV 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。24 アナリスト機関Gerhard SchwarzBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchSarah RobertsBarclays21 その他のアナリストを表示
お知らせ • Feb 07Redcare Pharmacy NV to Report Q2, 2026 Results on Jul 29, 2026Redcare Pharmacy NV announced that they will report Q2, 2026 results on Jul 29, 2026
お知らせ • Jan 08Redcare Pharmacy NV to Report Fiscal Year 2025 Final Results on Mar 04, 2026Redcare Pharmacy NV announced that they will report fiscal year 2025 final results at 9:00 AM, Central European Standard Time on Mar 04, 2026
お知らせ • Oct 07Redcare Pharmacy NV to Report Q3, 2025 Results on Oct 29, 2025Redcare Pharmacy NV announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Mar 19Redcare Pharmacy NV to Report Q2, 2025 Results on Jul 29, 2025Redcare Pharmacy NV announced that they will report Q2, 2025 results on Jul 29, 2025
お知らせ • Mar 11Redcare Pharmacy NV to Report Q1, 2025 Results on May 06, 2025Redcare Pharmacy NV announced that they will report Q1, 2025 results on May 06, 2025
お知らせ • Jan 09Redcare Pharmacy NV to Report Fiscal Year 2024 Final Results on Mar 11, 2025Redcare Pharmacy NV announced that they will report fiscal year 2024 final results on Mar 11, 2025
お知らせ • Apr 17Redcare Pharmacy N.V. Announces Board Appointment, Effective April 15, 2026Redcare Pharmacy N.V. announced that at its Annual General Meeting held on April 15, 2026, the shareholders voted with an absolute majority for all agenda items, including the appointment of Anja Hendel, Max Müller and Peter Schmid von Linstow as new members of the Supervisory Board. The Supervisory Board now consists of Michael Köhler (Chairman), Peter Schmid von Linstow (Vice-Chairman), Stephan Weber, Anja Hendel and Max Müller.
お知らせ • Feb 07Redcare Pharmacy NV to Report Q2, 2026 Results on Jul 29, 2026Redcare Pharmacy NV announced that they will report Q2, 2026 results on Jul 29, 2026
お知らせ • Jan 28Redcare Pharmacy N.V. Supports Seamless Continuation Of Digital E-Prescription Journey With PoPP Draft SpecificationsRedcare Pharmacy N.V. reported that the national agency responsible for the digitalization of the healthcare system in Germany (gematik) has published the draft specifications of the PoPP (Proof of Patient Presence) module for remote care use case, including the digital redemption of e-prescriptions. PoPP is intended to replace the current VSDM++ patient card verification process on which Redcare’s CardLink solution is based. In its current draft form, the PoPP specifications confirm the continuation of a smooth, low-threshold digital process for e-prescription redemption using Redcare’s Shop Apotheke app in Germany. The ability to verify the eGK and a patient’s insured status without PIN on the app can continue now even more effectively, since an SMS for mobile number verification will no longer be required. Combined with the added optionality of using a digital ID in the future, this ensures stability, more flexibility and supports the continued adoption of digital solutions. The migration to PoPP is part of a broader modernization of Germany’s telematics infrastructure. The new technology raises security standards for data protection while enabling more flexible, software-based authentication options. Beyond enhanced security, this approach is expected to improve accessibility to healthcare services, particularly in remote and digital care settings. Following the publication of the final PoPP specifications for the remote care use case – anticipated in the First Quarter 2026 – Redcare Pharmacy will finalize the technical implementation within its Shop Apotheke app and secure the required regulatory approvals. The official rollout of PoPP Stufe 2 – Online Check-in by gematik is currently planned for the end of 2026. Redcare Pharmacy’s CardLink license extension remains valid until January 31, 2027, providing ample runway for a smooth and well-managed transition.
お知らせ • Jan 08Redcare Pharmacy NV to Report Fiscal Year 2025 Final Results on Mar 04, 2026Redcare Pharmacy NV announced that they will report fiscal year 2025 final results at 9:00 AM, Central European Standard Time on Mar 04, 2026
お知らせ • Nov 12+ 1 more updateRedcare Pharmacy NV Designates Hendrik Krampe as Chief Financial Officer, Effective 1 December 2025Redcare Pharmacy announced that the Supervisory Board has designated Hendrik Krampe as Chief Financial Officer, effective 1 December 2025. The appointment of Hendrik Krampe is on the agenda of the Annual General Meeting to be held in April 2026 for consultation. The appointment of Hendrik Krampe is on the agenda of the Annual General Meeting to be held in April 2026 for consultation. Hendrik Krampe has twenty years of experience in the financial management of fast growing e-commerce businesses. Since 2014, he worked at Amazon where he held the role of Finance Director of the European marketplace business for the last eight years. From 2004 to 2014, Hendrik was at eBay in Germany as well as in the US in various roles including Finance Director of eBay’s Retail Media business. His broad expertise in efficiently scaling digital businesses, particularly marketplaces and Retail Media, complements Redcare Pharmacy´s strategy and will strengthen its core Rx and OTC business. The planned appointment of Hendrik comes at a time of continued growth momentum following strong third quarter results. It will support the company’s aim to increasingly capture economies of scale and improve profitability.
お知らせ • Oct 07Redcare Pharmacy NV to Report Q3, 2025 Results on Oct 29, 2025Redcare Pharmacy NV announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Sep 28Redcare Pharmacy NV Announces Stepping Down of Jasper Eenhorst from the Management BoardRedcare Pharmacy NV announced that Jasper Eenhorst will stepping down from the Managing Board, but will remain with the company until the end of this year to support a smooth transition to his successor.
お知らせ • Mar 19Redcare Pharmacy NV to Report Q2, 2025 Results on Jul 29, 2025Redcare Pharmacy NV announced that they will report Q2, 2025 results on Jul 29, 2025
お知らせ • Mar 13Redcare Pharmacy NV Provides Earnings Guidance for 2025Redcare Pharmacy NV provided earnings guidance for 2025. The company expects Total sales growth in excess of 25%.
お知らせ • Mar 11Redcare Pharmacy NV to Report Q1, 2025 Results on May 06, 2025Redcare Pharmacy NV announced that they will report Q1, 2025 results on May 06, 2025
お知らせ • Jan 09Redcare Pharmacy NV to Report Fiscal Year 2024 Final Results on Mar 11, 2025Redcare Pharmacy NV announced that they will report fiscal year 2024 final results on Mar 11, 2025
お知らせ • Oct 04Redcare Pharmacy NV Revises Sales Guidance for the Full Year 2024Redcare Pharmacy NV revised sales guidance for the full year 2024. The company expected for the full year 2024 that sales will end up slightly higher than predicted at the start of the year, and new guidance is total sales between EUR 2.35 billion and EUR 2.5 billion.
お知らせ • Jul 30Redcare Pharmacy NV (XTRA:RDC) acquired MediService AG.Redcare Pharmacy NV (XTRA:RDC) acquired MediService AG on mid-May last year. Redcare Pharmacy NV (XTRA:RDC) completed the acquisition of MediService AG on mid-May last year.
お知らせ • Mar 07Redcare Pharmacy NV Announces Management DeparturesThe Supervisory Board of Redcare Pharmacy NV agreed to the early departure request of the Managing Board members Stephan Weber (CCO) and Marc Fischer (CIO) at the Annual General Meeting on 17 April 2024. This decision comes at an ideal time to transition leadership responsibilities approximately one year before the end of their regular terms of office. This succession plan had been carefully developed and is the result of an extensive evaluation and selection process. Both Stephan Weber and Marc Fischer have agreed with the Supervisory Board to serve Redcare Pharmacy in an advisory capacity until October 2026, provided the relevant agenda item is approved by the Annual General Meeting.
お知らせ • Mar 06+ 2 more updatesRedcare Pharmacy NV to Report Q3, 2024 Results on Nov 05, 2024Redcare Pharmacy NV announced that they will report Q3, 2024 results on Nov 05, 2024
お知らせ • Mar 05Redcare Pharmacy NV, Annual General Meeting, Apr 17, 2024Redcare Pharmacy NV, Annual General Meeting, Apr 17, 2024, at 10:00 Central European Standard Time. Agenda: To consider directorate changes.
お知らせ • Dec 20+ 3 more updatesShop Apotheke Europe N.V. to Report Fiscal Year 2022 Results on Mar 07, 2023Shop Apotheke Europe N.V. announced that they will report fiscal year 2022 results at 9:00 AM, Central European Standard Time on Mar 07, 2023